Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Long-chain triazolyl acids as inhibitors of osteoclastogenesis.

Marshall AJ, Lin JM, Grey A, Reid IR, Cornish J, Denny WA.

Bioorg Med Chem. 2013 Jul 15;21(14):4112-9. doi: 10.1016/j.bmc.2013.05.013. Epub 2013 May 16.

PMID:
23726411
2.

Synthesis of substituted triazolyl curcumin mimics that inhibit RANKL-induced osteoclastogenesis.

Park SK, Oh S, Shin HK, Kim SH, Ham J, Song JS, Lee S.

Bioorg Med Chem Lett. 2011 Jun 15;21(12):3573-7. doi: 10.1016/j.bmcl.2011.04.106. Epub 2011 Apr 28.

PMID:
21570847
3.

Reaction of 3-Amino-1,2,4-Triazole with Diethyl Phosphite and Triethyl Orthoformate: Acid-Base Properties and Antiosteoporotic Activities of the Products.

Miszczyk P, Wieczorek D, Gałęzowska J, Dziuk B, Wietrzyk J, Chmielewska E.

Molecules. 2017 Feb 8;22(2). pii: E254. doi: 10.3390/molecules22020254.

4.

Application of click chemistry towards an efficient synthesis of 1,2,3-1H-triazolyl glycohybrids as enzyme inhibitors.

Anand N, Jaiswal N, Pandey SK, Srivastava AK, Tripathi RP.

Carbohydr Res. 2011 Jan 3;346(1):16-25. doi: 10.1016/j.carres.2010.10.017. Epub 2010 Oct 26.

PMID:
21129735
5.

Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism.

Zou W, Hakim I, Tschoep K, Endres S, Bar-Shavit Z.

J Cell Biochem. 2001 Jun 26-Jul 25;83(1):70-83.

PMID:
11500955
6.

Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice.

Tyagi AM, Gautam AK, Kumar A, Srivastava K, Bhargavan B, Trivedi R, Saravanan S, Yadav DK, Singh N, Pollet C, Brazier M, Mentaverri R, Maurya R, Chattopadhyay N, Goel A, Singh D.

Mol Cell Endocrinol. 2010 Aug 30;325(1-2):101-9. doi: 10.1016/j.mce.2010.05.016. Epub 2010 Jun 4.

PMID:
20570709
7.

Development and characterization of biphenylsulfonamides as novel inhibitors of bone resorption.

Greig IR, Idris AI, Ralston SH, van't Hof RJ.

J Med Chem. 2006 Dec 14;49(25):7487-92.

PMID:
17149877
8.

IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo.

Morita Y, Kitaura H, Yoshimatsu M, Fujimura Y, Kohara H, Eguchi T, Yoshida N.

Calcif Tissue Int. 2010 Mar;86(3):242-8. doi: 10.1007/s00223-010-9335-6. Epub 2010 Jan 29.

PMID:
20111957
9.

Rapid preparation of triazolyl substituted NH-heterocyclic kinase inhibitors via one-pot Sonogashira coupling-TMS-deprotection-CuAAC sequence.

Merkul E, Klukas F, Dorsch D, Grädler U, Greiner HE, Müller TJ.

Org Biomol Chem. 2011 Jul 21;9(14):5129-36. doi: 10.1039/c1ob05586k. Epub 2011 May 31.

PMID:
21625704
10.

Glutamate suppresses osteoclastogenesis through the cystine/glutamate antiporter.

Hinoi E, Takarada T, Uno K, Inoue M, Murafuji Y, Yoneda Y.

Am J Pathol. 2007 Apr;170(4):1277-90.

11.
12.

Click chemistry: 1,2,3-triazoles as pharmacophores.

Agalave SG, Maujan SR, Pore VS.

Chem Asian J. 2011 Oct 4;6(10):2696-718. doi: 10.1002/asia.201100432. Epub 2011 Aug 29. Review.

PMID:
21954075
13.

T-cell leukemia translocation-associated gene (TCTA) protein is required for human osteoclastogenesis.

Kotake S, Nanke Y, Kawamoto M, Yago T, Udagawa N, Ichikawa N, Kobashigawa T, Saito S, Momohara S, Kamatani N, Yamanaka H.

Bone. 2009 Oct;45(4):627-39. doi: 10.1016/j.bone.2009.06.019. Epub 2009 Jun 25.

PMID:
19560569
14.
15.

The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro.

Yuan J, Akiyama M, Nakahama K, Sato T, Uematsu H, Morita I.

Prostaglandins Other Lipid Mediat. 2010 Jun;92(1-4):85-90. doi: 10.1016/j.prostaglandins.2010.04.001. Epub 2010 Apr 13.

PMID:
20394833
16.
17.

Synthesis of 5-halogenated 1,2,3-triazoles under stoichiometric Cu(I)-mediated azide-alkyne cycloaddition (CuAAC or 'Click Chemistry').

Goyard D, Praly JP, Vidal S.

Carbohydr Res. 2012 Nov 15;362:79-83. doi: 10.1016/j.carres.2012.08.014. Epub 2012 Sep 11.

PMID:
23124169
18.

Efficient synthesis and in vitro cytostatic activity of 4-substituted triazolyl-nucleosides.

El Akri K, Bougrin K, Balzarini J, Faraj A, Benhida R.

Bioorg Med Chem Lett. 2007 Dec 1;17(23):6656-9. Epub 2007 Sep 29.

PMID:
17931862
19.

Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.

O'Sullivan S, Naot D, Callon K, Porteous F, Horne A, Wattie D, Watson M, Cornish J, Browett P, Grey A.

J Bone Miner Res. 2007 Nov;22(11):1679-89.

20.

Caffeine enhances osteoclast differentiation from bone marrow hematopoietic cells and reduces bone mineral density in growing rats.

Liu SH, Chen C, Yang RS, Yen YP, Yang YT, Tsai C.

J Orthop Res. 2011 Jun;29(6):954-60. doi: 10.1002/jor.21326. Epub 2011 Jan 31.

Supplemental Content

Support Center